CIT
protein-codingcitron rho-interacting serine/threonine kinase, the group of AGC family kinases|MicroRNA protein coding host genes
Gene summary
This gene encodes a serine/threonine-protein kinase that functions in cell division. Together with the kinesin KIF14, this protein localizes to the central spindle and midbody, and functions to promote efficient cytokinesis. This protein is involved in central nervous system development. Polymorphisms in this gene are associated with bipolar disorder and risk for schizophrenia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2011]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~191.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0014908
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0014908
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0014908
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0016660
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CIT variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001206999.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 8 | 133 | 10 | 151 | ||
| missense | 4 | 2 | 304 | 26 | 2 | 338 |
| nonsense | 6 | 2 | 3 | 11 | ||
| start loss | 0 | |||||
| frameshift | 4 | 2 | 6 | |||
| splice donor/acceptor (+/-2bp) | 2 | 3 | 9 | 14 | ||
| Total | 16 | 9 | 324 | 159 | 12 | 520 |
Highest pathogenic variant AF is 0.000024279158
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001193928.1 | 47 | MANE Select | |
| Ensembl | ENSP00000376306.2 | 47 | MANE Select | |
| RefSeq | NP_009105.1 | 46 | Standard | |
| Ensembl | ENSP00000261833.7 | 46 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- G13 Signaling Pathway
- Signal Transduction
- RHO GTPases activate CIT
- RHO GTPase Effectors
- Signaling by Rho GTPases
Biological Process
- G2/M transition of mitotic cell cycle
- mitotic cell cycle
- mitotic cytokinesis
- protein phosphorylation
- Golgi organization
Molecular Function
- protein serine/threonine kinase activity
- protein binding
- ATP binding
- Rho GTPase binding
- SH3 domain binding
Cellular Component
- cytosol
- membrane
- midbody
- Golgi cisterna
- cleavage furrow
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000392521
- Coding exons
- 47
- Length
- 191501
- Individuals with no LoFs
- 125701
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 46
- Defined
- 125747
- p
- 0.000183
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 3.82 | 825 | 1.20e+3 | 0.689 | 0.0000743 | 13576 |
| Missense (PolyPhen) | 234 | 381.37 | 0.61358 | 4263 | ||
| Synonymous | 1.10 | 442 | 472 | 0.936 | 0.0000301 | 3901 |
| Loss of Function | 8.44 | 23 | 125 | 0.185 | 0.00000699 | 1397 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00012 | 0.00012 | rare |
| Latino/Admixed American | 0.00015 | 0.00014 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00016 | 0.00016 | rare |
| Finnish | 0.000093 | 0.000092 | rare |
| European (Non-Finnish) | 0.00027 | 0.00025 | rare |
| South Asian | 0.00017 | 0.00016 | rare |
| Other | 0.00017 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Plays a role in cytokinesis. Required for KIF14 localization to the central spindle and midbody. Putative RHO/RAC effector that binds to the GTP-bound forms of RHO and RAC1. It probably binds p21 with a tighter specificity in vivo. Displays serine/threonine protein kinase activity. Plays an important role in the regulation of cytokinesis and the development of the central nervous system. Phosphorylates MYL9/MLC2. {ECO:0000269|PubMed:16236794, ECO:0000269|PubMed:16431929, ECO:0000269|PubMed:21457715, ECO:0000269|PubMed:27453578}.;
- Disease
- DISEASE: Microcephaly 17, primary, autosomal recessive (MCPH17) [MIM:617090]: A form of microcephaly, a disease defined as a head circumference more than 3 standard deviations below the age, sex and ethnically matched mean. Brain weight is markedly reduced and the cerebral cortex is disproportionately small. MCPH17 is a severe form characterized by lissencephaly, enlarged ventricles, agenesis of the corpus callosum, cerebellar hypoplasia, and brainstem hypoplasia. Patients manifest delayed psychomotor development, intellectual disability, spasticity, axial hypotonia, and dysmorphic features. {ECO:0000269|PubMed:27453578, ECO:0000269|PubMed:27453579, ECO:0000269|PubMed:27503289, ECO:0000269|PubMed:27519304}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.371
Intolerance Scores
- LoFtool
- 0.475
- RVIS EVS
- -2.35
- RVIS percentile EVS
- 1.14
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- E
- Indispensability pred.
- E
- Indispensability score
- 0.858
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |